Skip to content
Independent Medical Alliance
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate
  • My Accountmy account
  • Home
    Latest Updates

    Stay up-to-date with the latest news from our fast-moving field.

    View
    Blog

    Subscribe to our blog to read our weekly news capsule and be the first to receive the latest announcements from IMA.

    Read Now
    In the News

    Read media coverage of IMA from around the world.

    View
  • TREATMENT
    Treatment Guidelines

    Strategies to prevent and treat COVID-19, Long COVID, RSV, Flu and Vaccine-related issues:

    • Prevention
    • Treatment
    • Long COVID Recovery
    • Vaccine Injury Prevention
    • Shedding from Vaccines
    • Long Vax Recovery

    Strategies to prevent and treat conditions like cancer, depression, insulin resistance and more:

    • Brain Health
    • Cancer Resource Hub
    • Depression & Mental Health
    • Fasting & Healthy Eating
    • Insulin Resistance
    • Sepsis
  • Resources
    Wondering where to begin?

    Let us help you find what you’re looking for. We know COVID-19 can be overwhelming; click below to learn more about the resources available to you on this website.

    get started
    Patient Resources
    • Find a Provider
    • Find a Pharmacy
    • Tools & Guides
    • Testimonials
    • FAQ
    Professional Resources
    • Journal of Independent Medicine

    • Research
    • Ivermectin Facts
    • Informed Consent
    • Join the Alliance
  • Education
    About the education portal

    IMA’s goal is to educate healthcare providers and empower patients with the tools and resources they need to take control of their own health.

    Education on Demand

    Stream video lectures, download slide presentations, and get exclusive access to key facts, data, and references from IMA (formerly FLCCC) educational programs.

    • My Content
    • Explore Courses
  • Community
    Events

    IMA hosts dynamic events that unite top experts from diverse fields for learning, sharing, and collaboration. Join us for unique in-person and virtual experiences that foster knowledge exchange and meaningful partnerships.

    • Weekly Webinar

    • Annual Conference
    Forums

    Join the discussion! IMA public and private forums are a place for the IMA community to connect without fear of censorship.

    • Forums
    Membership

    Explore IMA (formerly FLCCC) membership options for healthcare professionals and committed individuals who share a common passion and purpose. Members receive access to private forums and exclusive content and events while supporting IMA’s mission.

    • Join Now
    • Sign In
  • About
    About the IMA

    Learn about the history of IMA (formerly FLCCC), our mission and vision, and how you can get involved.

    learn more
    • Founders & Clinical Team
    • Senior Fellows
    • Contributors
    • Partners
    • Connect with Us
    • Advocacy
    • Impact Reports
    • Annual Reports
    • Support Us
    • Shop our Store
  • Search
    Search for:
  • IMA HOME
    • Latest UpdatesGet the latest updates from the FLCCC Alliance and their work on COVID-19 prevention and treatment.
    • Blog
    • In the NewsCheck out the latest in news coverage focused on the FLCCC Alliance and our members!
  • TREATMENT
    • Prevention
    • Treatment
    • Recovery
    • More Protocols
      • Brain Health
      • Cancer Resource Hub
      • Depression & Mental Health
      • Eat Well
      • Insulin Resistance
      • Sepsis Care
      • Shedding from Vaccines
  • RESOURCES
    • Journal of Independent Medicine
    • Research
    • Tools & Guides
    • Find a Provider
    • Find a Pharmacy
    • FAQ
    • Efficacy of Ivermectin
    • Join The Alliance
  • EDUCATION
    • Courses
  • COMMUNITY
    • Events
      • Annual Conference 2026
      • Weekly WebinarsJoin FLCCC’s live webinars every Wednesday at 7 pm ET for the latest updates on COVID news & treatment options. Hear from experts, get questions answered!
    • Forums
    • Membership
  • ABOUT
    • Founders & Clinical Team
    • Senior Fellows
    • IMA Contributors
    • Partners
    • Annual Reports
    • Impact Reports
    • Connect with Us
Independent Medical Alliance
  • MY ACCOUNT
  • MY FORUMS
  • MY COURSES
Search for:
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate

References

Categories

Cancer Care (474) I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (288)

Tags

ACE2 protein (10) acute respiratory distress syndrome (21) Anti-inflammatory (13) Antidepressants (9) Ascorbic Acid (13) autoantibodies (10) autophagy (48) Breast Cancer (30) Cancer (69) Cancer Stem Cells (11) Chemotherapy (12) Colon Cancer (11) Corticosteroids (9) COVID-19 (330) COVID-19 Vaccines (8) Curcumin (14) Cytokines (13) Depression (12) Diabetes (14) Famotidine (14) Hydroxychloroquine (15) Hyperbaric Oxygen Therapy (9) Inflammation (15) intermittent fasting (14) ivermectin (53) long COVID (21) Macrophages (18) Mast Cells (8) Melatonin (23) Mitochondria (14) Myeloid Cells (10) Pneumonia (9) quercetin (15) resveratrol (11) SARS-CoV-2 (83) Sepsis (22) spermidine (11) Spike Protein (12) Thiamine (11) Thrombosis (9) Tinnitus (12) Tumor (41) Vitamin C (30) Vitamin D (29) Zinc (12)
  • Reference: Synergistic effect of quercetin and vitamin C against COVID-19: Is a possible guard for front liners?

    Published On: November 16, 2020

    Authors: Arslan B, Ergun NU, Topuz S, Semerci SY, Suner N. DOI: 10.2139/ssrn.3682517 Abstract Background: While waiting for vaccine, hygiene measures, social distance and personal protective equipment are the only basic protection against Novel Coronavirus. However, these are not sufficient to protect healthcare workers.This study aimed to evaluate if quercetin and vitamin C could be [...]

    Categories: I-CARE Early Covid, MATH+

    Tags: COVID-19, quercetin, Vitamin C

  • Reference: SARS-CoV-2 infection depends on cellular heparan sulphate and ACE2.

    Published On: November 12, 2020

    Authors: Clausen TM, Sandoval DR, Spliid CB, PiHl J, Painter CD, Thacker BE et al. PMID: 32970989 PMCID: PMC7489987 DOI: 10.1016/j.cell.2020.09.033 Abstract We show that SARS-CoV-2 spike protein interacts with both cellular heparan sulfate and angiotensin-converting enzyme 2 (ACE2) through its receptor-binding domain (RBD). Docking studies suggest a heparin/heparan sulfate-binding site adjacent to the ACE2-binding [...]

    Categories: MATH+

    Tags: ACE2 protein, SARS-CoV-2

  • Reference: Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study.

    Published On: November 12, 2020

    Authors: Abou-Arab O, Huette P, Debouvries F, Dupont H, Jounieaux V PMID: 33183348 PMCID: PMC7661015 DOI: 10.1186/s13054-020-03371-x Abstract The role of inhaled nitric oxide (iNO) in the management of severe hypoxia due to coronavirus disease 2019 (Covid-19) is a subject of debate. Despite the lack of clinical data, the surviving sepsis campaign recommended the use [...]

    Categories: MATH+

    Tags: COVID-19, Nitric Oxide

  • Reference: Airborne spread of SARS-CoV-2 while using high-flow nasal cannula oxygen therapy: myth or reality.

    Published On: November 10, 2020

    Authors: Haymet A, Bassi GL, Fraser JF PMID: 33170330 PMCID: PMC7652914 DOI: 10.1007/s00134-020-06314-w Abstract In 2020, a new pandemic caused by SARS-CoV-2 was declared, and since the first cases of coronavirus disease 2019 (COVID-19), clinicians had to apply different modes of respiratory support, previously used on patients with severe respiratory failure from other etiologies. In [...]

    Categories: MATH+

    Tags: SARS-CoV-2

  • Reference: CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and deceases SARS-CoV2 RNA in plasma by day 14.

    Published On: November 10, 2020

    Authors: Patterson BK, seethamraju H, Dhody K, Corley MJ, Kazempour K, Lalezari J et al. PMID: 33186704 PMCID: PMC7654230 DOI: 10.1016/j.ijid.2020.10.101 Abstract Objective: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now a global pandemic. Emerging results indicate a dysregulated immune response. Given the role of CCR5 in immune cell migration and inflammation, [...]

    Categories: I-RECOVER Long Covid, MATH+

    Tags: CCR5, COVID-19

  • Reference: Rescue thearpy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome.

    Published On: November 4, 2020

    Authors: Bagate F, Tuffet S, Masi P, Perier F, Razazi K PMID: 33150525 PMCID: PMC7641257 DOI: 10.1186/s13613-020-00769-2 Abstract Background: In COVID-19 patients with severe acute respiratory distress syndrome (ARDS), the relatively preserved respiratory system compliance despite severe hypoxemia, with specific pulmonary vascular dysfunction, suggests a possible hemodynamic mechanism for VA/Q mismatch, as hypoxic vasoconstriction alteration. [...]

    Categories: MATH+

    Tags: acute respiratory distress syndrome, COVID-19

  • Reference: N-Acetylcysteine to combat COVID-19: an evidence review.

    Published On: November 2, 2020

    Authors: Shi Z, Puyo CA PMID: 33177829 PMCID: PMC7649937 DOI: 10.2147/TCRM.S273700 Abstract The novel coronavirus disease (COVID-19) is caused by a virus (SARS-Cov-2) and is known for inducing multisystem organ dysfunction associated with significant morbidity and mortality. Current therapeutic strategies for COVID-19 have failed to effectively reduce mortality rate, especially for elderly patients. A newly [...]

    Categories: I-CARE Early Covid, I-RECOVER Long Covid, I-RECOVER Post-Vaccine, MATH+

    Tags: COVID-19, N-Acetylcysteine

  • Reference: Coronavirus disease 2019 acute respiratory failure: Almitrine drug resuscitaion or resuscitating patients by almitrine?

    Published On: November 1, 2020

    Authors: Payen D DOI:10.1097/CCM.0000000000004765 Abstract OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortality have been identified as critically important core outcomes by more than 9300 patients, health professionals, and the public from 111 countries in the global coronavirus disease 2019 core outcome set initiative. The aim of this project was to [...]

    Categories: MATH+

    Tags: Acute Respiratory Failure, COVID-19

  • Reference: Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Bagdad, Iraq

    Published On: October 27, 2020

    COVID-19 patients suffer from the lack of curative therapy. Hence, there is an urgent need to try repurposed old drugs on COVID-19. Methods Randomized controlled study on 70 COVID-19 patients (48 mild-moderate, 11 severe, and 11 critical patients) treated with 200ug/kg PO of Ivermectin per day for 2-3 days along with 100mg PO doxycycline twice per day for 5-10 days plus standard therapy; the second arm is 70 COVID-19 patients (48 mild-moderate and 22 severe and zero critical patients) on standard therapy. The time to recovery, the progression of the disease, and the mortality rate were the outcome-assessing parameters.

    Categories: I-CARE Early Covid, MATH+

    Tags: Doxycyline, Iraq, Ivermectin (with Doxycycline)

  • Reference: Chest CT findings in Coronavirus disease 2019 (COVID-19): relationship to duration of infection.

    Published On: October 25, 2020

    Authors: Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N et al. PMID: 33142125 PMCID: PMC7585632 DOI: 10.1016/j.clinimag.2020.10.035 Abstract Objectives: We performed a systematic review and meta-analysis of the prevalence of chest CT findings in patients with confirmed COVID-19 infection. Methods: Systematic review of the literature was performed using PubMed, Scopus, Embase, [...]

    Categories: MATH+

    Tags: Chest CT, COVID-19

Previous91011Next
FLCCC Logo with white letters
Support Us

We are a 100% donor-supported 501(c)(3) non-profit organization. Our work would not be possible without you! Help us expand our reach and share life-saving research.

Give Now
shop
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About the IMA
  • Protocols

  • Providers

  • Testimonials

  • Latest Updates

  • Newsletter Signup

Follow Us
FLCCC Logo with white letters
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About IMA
  • Protocols
  • Providers
  • Testimonials
  • Latest Updates
  • Newsletter Signup
Support Us
Give Now
shop
Follow Us
Disclaimer

©2020–2025 All Rights Reserved Independent Medical Alliance (IMA), formerly FLCCC Alliance. The information contained or presented on this website is for educational purposes only. Information on this site is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional. The facts presented are offered as information only in order to empower you – our protocol is not medical advice – and in no way should anyone infer that we, even though we are physicians, or anyone appearing in any content on this website are practicing medicine, it is for educational purposes only. Any treatment protocol you undertake should be discussed with your physician or other licensed medical professional. Seek the advice of a medical professional for proper application of ANY material on this site or our program to your specific situation. NEVER stop or change your medications without consulting your physician. If you are having an emergency contact your emergency services: in the USA that’s 911. IMA does not use SMS to conduct marketing campaigns, however, we are required to provide the following disclaimer: By providing my phone number to “IMA”, I agree and acknowledge that “IMA” may send text messages to my wireless phone number for any purpose. Message and data rates may apply. Message frequency will vary, and you will be able to Opt-out by replying “STOP”. For information on data handling, terms of use, and disclaimers, visit our Privacy Policy & Terms.

© Copyright 2026. Independent Medical Alliance (IMA), formerly FLCCC Alliance.

Page load link
We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so. Read our Privacy Policy ACCEPT

Ask Our Experts

Have a question you don’t see on our list? Complete the form below with a question or topic you’d like our experts to consider adding to our FAQs resource center. Questions will not be answered individually (we cannot provide medical advice or treatment through this form).

Please enable JavaScript in your browser to complete this form.
Opt In
Loading

Disclaimer: We are unable to offer individualized medical advice, diagnoses, or treatment recommendations. For any personal medical decisions, always consult with your own healthcare provider.

Join us at IMA 2026

Join us April 17-18 for IMA 2026, a two-day event in Texas covering the latest innovations, research, and forward-thinking practices shaping the future of healthcare. Earn 12.75 Continuing Education Credits!

Buy Tickets Now

Go to Top